- Home
- GNS vs TELA Comparison
GNS vs TELA Comparison
Compare GNS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNS | TELA |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1M | 37.5M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GNS | TELA |
|---|---|---|
| Price | $0.34 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.31 |
| AVG Volume (30 Days) | ★ 772.4K | 59.4K |
| Earning Date | 03-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,300,000.00 |
| Revenue This Year | $220.56 | $18.41 |
| Revenue Next Year | N/A | $15.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.56 |
| 52 Week Low | $0.21 | $0.67 |
| 52 Week High | $1.92 | $2.19 |
Technical Indicators
Market Signals| Indicator | GNS | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 43.51 |
| Support Level | $0.30 | $0.67 |
| Resistance Level | $0.48 | $1.20 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 0.86 | 27.29 |
Price Performance
Historical ComparisonAbout GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.